22.00USDMkt Cap: 1.52B USDP/E: —Last update: 2026-05-21
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a prote…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Company
Market Cap1.52B USD
Enterprise Value1.80B USD
Revenue (TTM)87.16M USD
Gross Profit41.70M USD
Net Income (TTM)-29.82M USD
Revenue/Share7.387 USD
Last Price22.00 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees222
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-31.26
PEG—
EV/EBITDA-56.13
EV/Revenue20.66
P/S17.50
P/B-8.56
EPS (TTM)-0.65
EPS (Forward)-0.70
52W Range
20.2188% of range22.24
52W High22.24 USD
52W Low20.21 USD
Profitability
Gross Margin56.20%
Oper. Margin-47.42%
EBITDA Margin-36.81%
Profit Margin-40.18%
ROE18.76%
ROA-21.30%
Growth
Revenue Growth98.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-53.61M USD
CapEx (TTM)6.38M USD
FCF Margin—
FCF Yield—
Net Debt40.96M USD
Net Debt/EBITDA-1.28
Balance Sheet
Debt/Equity-0.26
Current Ratio5.88
Quick Ratio3.50
Book Value/Sh-2.5690 USD
Cash/Share0.9320 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)30.00 USD
Target Range27.00 USD – 35.00 USD
# Analysts5
Ownership
Shares Out.69.31M
Float34.22M
Insiders26.67%
Institutions28.31%
Short Interest
Short Ratio1.3d
Short % Float2.77%
Short % Out.1.69%
Shares Short1.15M
Technical
SMA 5023.41 (-6.0%)
SMA 20023.41 (-6.0%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)335.78K
Avg Vol (10d)224.99K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—